Vanda Pharmaceuticals (VNDA) Prepares to Explore Sale - Reuters

September 22, 2016 3:44 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

(Updated - September 22, 2016 3:46 PM EDT)

Vanda Pharmaceuticals (NASDAQ: VNDA) is preparing to consider strategic alternatives including a potential sale, according to Reuters, citing people familiar. The company is said to be holding conversations with investment banks about naming a financial adviser to help it review options.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment